36C26122Q0288_1.docx

DOCX document 15 KB Posted

Attached to
6505--Notice of Intent: PYLARIFY (piflufolastat F 18) Radiopharmaceutical Base plus 4 OY
Solicitation number
36C26122Q0288
Issued by

View the file

Other files

File Type Posted
LSJ-36C261-22-AP-2448 Pylarify-SAM_Redacted.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Presolicitation Notice Presolicitation Notice

SUBJECT*
Notice of Intent: PYLARIFY (piflufolastat F 18) Radiopharmaceutical Base plus 4 OY

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
96819-1522
SOLICITATION NUMBER*
36C26122Q0288

RESPONSE DATE/TIME/ZONE

ARCHIVE
30 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412
PLACE OF PERFORMANCE
Department of Veterans Affairs

VA Sierra Pacific Network (VISN 21)

VA Palo Alto Health Care System

3801 Miranda Avenue

Palo Alto CA

POSTAL CODE
94304

COUNTRY

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

VA Sierra Pacific Network (VISN 21) Network Contracting Office (NCO) 21 3375 Koapaka St. STE F250 Honolulu HI 96819-1522

POINT OF CONTACT*

Contract Specialist Moneque Rodriguez Moneque.Rodriguez@va.gov 808-539-1304

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

See attached document: LSJ-36C261-22-AP-2448 Pylarify-SAM_Redacted.

NOTICE OF INTENT TO SOLE SOURCE

Department of Veterans Affairs (VA) Network Contracting Office 21 (NCO 21) hereby gives notice of the Government’s intent to order against the VA National Acquisition Center (NAC) contract 36F79719D0170 for a period of performance of a base plus four option year with Progenics Pharmaceuticals, Inc. for Pylarify prostate-specific membrane antigen (PSMA) positive emission tomography (PET) prostate cancer imaging agent deliveries at the VA Palo Alto Health Care System: 3801 Miranda Avenue, Palo Alto, CA 94304. Pylarify, (Piflufolastat F-18), is a radioactive diagnostic agent indicated for positive emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It can be used for men with suspected metastasis who are candidates for initial definitive therapy or those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level.

Determination of this sole source procurement is in accordance with FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. It is the Government’s belief that the proposed candidate is the only provider of PSMA PET prostate cancer imaging agent that can meet the agency’s needs. The applicable North American Industry Classification System (NAICS) code is 325412 (Pharmaceutical Preparation Manufacturing) and the Federal Supply Code (FSC) is 6505(Drugs and Biologicals).

This notice of intent is not a request for competitive quotes. Any business that believes it can provide the PSMA PET prostate cancer imaging agent for VA Palo Alto Health Care System may give written notice to moneque.rodriguez@va.gov by 3:00PM Hawaii Time on Thursday, March 17, 2022. All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. Responses will be considered by the Government; however, a determination by the Government not to compete the proposed acquisition based upon responses of this notice is solely within the discretion of the Government.

THIS SYNOPSIS DOES NOT COMMIT THE GOVERNMENT TO CONTRACT FOR ANY SUPPLY OR SERVICE. THE GOVERNMENT WILL NOT PAY FOR ANY INFORMATION OR ADMINISTRATIVE COSTS INCURRED IN RESPONSE TO THIS SYNOPSIS.

*=Required Field
Presolicitation Notice

Presolicitation Notice

File details come from the government source that posted it. Updated .